Gene Therapy Market Research Reports & Industry Analysis

The global GMP Viral Vector Manufacturing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. GMP viral vector man...

The global Viral and Non Viral Vector Manufacturing market size is predicted to grow from US$ 1942 million in 2025 to US$ 4518 million in 2032; it is expected to grow at a CAGR of 13.1% from 2026 to 2...

The global Adeno-Associated Virus Gene Therapy market size is predicted to grow from US$ 1798 million in 2025 to US$ 3008 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032. U...

The global Gene Therapy for Neurodegenerative Diseases market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United...

The global AAV Vector CDMO Services market size is predicted to grow from US$ 172 million in 2025 to US$ 681 million in 2032; it is expected to grow at a CAGR of 22.2% from 2026 to 2032. AAV (Adeno-As...

The global Viral Vector CDMO Services market size is predicted to grow from US$ 814 million in 2025 to US$ 3661 million in 2032; it is expected to grow at a CAGR of 24.4% from 2026 to 2032. Viral Vect...

The global AAV Manufacturing Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. AAV (Adeno-Associated Vir...

Antisense Oligonucleotides Market reached US$ 3,180.1 million in 2025 and is expected to reach US$ 5,286.96 million by 2033, growing with a CAGR of 6.50% during the forecast period 2026-2033. The Anti...

The global Gene Therapy in Cardiovascular Disorder market size is predicted to grow from US$ 593 million in 2025 to US$ 2317 million in 2032; it is expected to grow at a CAGR of 21.9% from 2026 to 203...

The global RNAi Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. RNAi Therapy is a new treatment method...

The global Gene Vector market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Gene Vector is...

The global In Vitro Gene Therapy market size was estimated at USD nan million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of nan% during the forecast period. This report o...

The global Viral Vector-Based Gene Therapy market size was estimated at USD nan million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of nan% during the forecast period. Thi...

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases,...

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells in...

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells in...

Gene therapy is the treatment of a genetic disease by the introduction of specific cell function-altering genetic material into a patient. The key step in gene therapy is efficient gene delivery to th...

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene i...

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene i...

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells in...

Cell and gene therapy (CGT) includes the injection of cells, genes, or gene-modified cells into a patient with the purpose of preventing or treating a disease. Cell therapy involves the injection of c...

Cell and Gene Therapy (CGT) drugs are a class of innovative treatments that treat diseases by changing the patient's cells or genes. Specifically, CGT drugs usually include: 1. Gene therapy: by introd...

In Vivo Gene Editing Market reached US$ 2.46 billion in 2025 and is expected to reach US$ 37.75 billion by 2035, growing with a CAGR of 34.09% during the forecast period 2026-2035. The In Vivo Gene Ed...

Viral Vector Manufacturing Marketis is growing with a CAGR of 20.30% during the forecast period 2026-2035. The Viral Vector Manufacturing Market emerges as a key focus in DataM Intelligence latest in-...

Small Interfering RNA (siRNA) Therapeutics Market reached US$ 2.99 billion in 2025 and is expected to reach US$ 14.54 billion by 2033, growing with a CAGR of 17.40% during the forecast period 2026-203...

Viral Vector and Plasmid DNA Manufacturing Marketis is growing with a CAGR of 14.20% during the forecast period 2026-2035. The Viral Vector and Plasmid DNA Manufacturing Market emerges as a key focus...

Gene Editing Delivery Technologies Market reached US$ 3.99 billion in 2025 and is expected to reach US$ 27.08 billion by 2035, growing with a CAGR of 21.12% during the forecast period 2026-2035. The G...

Japan Gene Therapy Market reached US$ 148.06 Million in 2024 and is expected to reach US$ 904.94 Million by 2033, growing with a CAGR of 20.30% during the forecast period 2026-2033. The Japan Gene The...

The global Cell Gene Overexpression Service market size is expected to reach $ 1236 million by 2032, rising at a market growth of 4.4% CAGR during the forecast period (2026-2032). Cell Gene Overexpres...

The Gene Therapies – Pipeline insights – Size, Share, Industry, Forecast and outlook (2026-2033) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delive...

The global gene therapy market size was valued at USD 6.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 19.3 Billion by 2034, exhibiting a CAGR of 12.27% from 2026-20...

The global viral vector & plasmid DNA manufacturing market size is expected to reach USD 882.9 million by 2025, ... are engaged in strategic mergers & facility acquisitions to meet growing requirements of viral vectors within the pharmaceutical and biotech industries and to broaden their ...

The gene therapy CDMO market size is expected to grow from US$ 2.60 billion in 2025 to US$ 14.17 billion by 2034; it is projected to register a CAGR of 20.3% during 2026-2034. The increasing prevalenc...

The global viral vector market size was estimated at USD 4.25 billion in 2025 and is projected to reach USD 10.22 billion by 2033, growing at a CAGR of 11.69% from 2026 to 2033. The increasing prevale...

According to our (Global Info Research) latest study, the global Custom Adeno-Associated Virus (AAV) Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$...

Cancer Gene Therapy Market reached US$3.97Billion in 2024 and is expected to reach US$ 19.97Billion by 2033, growing with a CAGR of 19.80% during the forecast period 2026-2033. The Cancer Gene Therapy...

The cell and gene therapy market size is expected to grow from US$ 5.30 billion in 2024 to US$ 25.78 billion by 2031; it is projected to register a CAGR of 25.5% during 2025-2031. The increasing preva...

... this report analyzes the top players in global market, and splits the Hemophilia Gene Therapy market by product type and applications/end ... and hospital visits, and transitioning patients from severe to mild hemophilia. The global Hemophilia Gene Therapy market is valued at xx million USD in 2017 and is ...

... with high investment in research marketing and they will monopoly position in the industry. The global Oncolytic Virus Therapy market is valued at 2 million ... top players in global market, and splits the Oncolytic Virus Therapy market by product type and applications/end industries. Market Segment by Companies, ...

The global Oncolytic Virus Therapy market size is expected to reach $ 236 million by 2032, rising at a market growth of 10.1% CAGR during the forecast period (2026-2032). Oncolytic Virus Therapy is an...

The global Hemophilia Gene Therapy market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Hemophilia is a rare bleeding disorder...

The North America Viral Vector And Plasmid DNA Manufacturing Market was valued at in and is anticipated to reach by 2029, at a CAGR of 0.25 from 2026 to 2032. The report delivers in-depth insights int...

SMN1 Gene Replacement Market reached US$ 1.21 billion in 2023 and is expected to reach US$ 1.76 billion by 2031, growing with a CAGR of 4.90% during the forecast period 2026-2031. The SMN1 Gene Replac...

The Global SCD/?-Thal Gene Therapy Outlook 2025–2033: Size, Trends, Key Players was valued at US$ 83.87 Million in 2024 and is anticipated to reach US$ 380.42 Million by 2033, at a CAGR of 0.184 from...

Nucleic Acid Therapeutics Market reached US$ 5.64 billion in 2024 and is expected to reach US$ 14.42 billion by 2032, growing with a CAGR of 10.90% during the forecast period 2026-2032. The Nucleic Ac...

Global Gene Transfer Technologies Market reached US$ 3.78 Billion in 2024 and is expected to reach US$ 8.74 Billion by 2033, growing with a CAGR of 9.80% during the forecast period 2026-2033. The Glob...

The Gene Therapy Market was valued at US$ 4.80 Billion in 2024 and is anticipated to reach US$ 35.91 Billion by 2033, at a CAGR of 0.231 from 2026 to 2032. The report delivers in-depth insights into k...

Europe Gene Therapy Market reached US$ 1,030.70 Million in 2024 and is expected to reach US$ 8,780.77 Million by 2033, growing with a CAGR of 24.90% during the forecast period 2026-2033. The Europe Ge...

Asia-Pacific Gene Therapy Market reached US$ 1.06 Billion in 2024 and is expected to reach US$ 14.59 Billion by 2033, growing with a CAGR of 34.10% during the forecast period 2026-2033. The Asia-Pacif...